Neil Chatterji
Stock Analyst at B. Riley Securities
(0)
# 3796
Out of 5,298 analysts
24
Total ratings
28.57%
Success rate
-7.54%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
CLPT ClearPoint Neuro | Maintains: Strong Buy | 15 20 | 11.04 | 81.16% | 2 | Jan 28, 2025 | |
OPRX OptimizeRx | Maintains: Buy | 17 13 | 7.71 | 68.61% | 3 | Dec 24, 2024 | |
AUGX Augmedix | Reinstates: Buy | 6 | n/a | n/a | 3 | Apr 3, 2024 | |
ESTA Establishment Labs H... | Maintains: Buy | 95 50 | 32.51 | 53.8% | 2 | Nov 9, 2023 | |
SILK Silk Road Medical | Downgrades: Neutral | 54 14 | n/a | n/a | 3 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 8 | 1.56 | 380.77% | 1 | Oct 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 15 18 | 13.13 | 37.09% | 2 | Sep 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 5 | 2.28 | 97.37% | 1 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 3 4 | 0.66 | 430.3% | 3 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 6 6 | 1.65 | 233.33% | 2 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 32 | 13.06 | 145.02% | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 10 | 2.03 | 367.98% | 1 | Oct 4, 2022 |